Development and validation of stability indicating reversed-phase hplc method for the determination of ezetimibe in pharmaceutical dosage forms

S. Pandey, M. Rathanand

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

In the present study, a simple, rapid and precise liquid chromatographic method was developed and validated for the determination of ezetimibe in its dosage form. The Ezetimibe was separated in a 100 × 4.6 mm i.d., C18 column, 3 μm particle sizes, Luna phenomenex, using a mobile phase composition of water and acetonitrile (60:40 v/v). Column oven temperature was kept at 25°C.The flow rate was 1.5 mL/min and the analyte monitored at 225 nm. The retention time of Ezetimibe was 8.47 min. The specificity of the method was determined by assessing interference from the placebo and by stress testing of the drug (forced degradation).The developed method was validated in terms of linearity, accuracy, precision, system suitability, limit of detection, limit of quantitation and solution stability. The proposed method was also applied successfully to the pharmaceutical dosage form self emulsified drug delivery without any interference by excipients.
Original languageEnglish
Pages (from-to)53-57
Number of pages5
JournalInternational Journal of Pharmaceutical Sciences Review and Research
Volume1
Issue number1
Publication statusPublished - 2010

Fingerprint Dive into the research topics of 'Development and validation of stability indicating reversed-phase hplc method for the determination of ezetimibe in pharmaceutical dosage forms'. Together they form a unique fingerprint.

  • Cite this